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Abstract
The hyaluronic acid (HA) receptor for endocytosis (HARE) is the pri-
mary scavenger receptor for HA and chondroitin sulfates in mam-
mals. The two human isoforms of HARE (full-length 315-kDa and a 
190-kDa proteolytic cleavage product), which are type I single-pass 
membrane proteins, are highly expressed in sinusoidal endothelial 
cells of lymph nodes, liver, and spleen. Their identical HARE cyto-
plasmic domains contain four candidate AP-2/clathrin-mediated en-
docytic signaling motifs as follows: YSYFRI2485, FQHF2495, NPLY2519, 
and DPF2534 (315-HARE numbering). Stably transfected cells express-
ing 190-HARE(ΔYSYFRI), 190-HARE(ΔFQHF), or 190-HARE(ΔNPLY) 
(lacking Motifs 1, 2, or 3) had decreased 125I-HA endocytosis rates 
of ~49, ~39, and ~56%, respectively (relative to wild type). In con-
trast, 190-HARE(ΔDPF) cells (lacking Motif 4) showed no change in 
HA endocytic rate. Deletions of motifs 1 and 2 or of 1, 2, and 4 de-
creased the rate of HA endocytosis by only ~41%. Endocytosis was 
~95% decreased in mutants lacking all four motifs. Cells expressing 
a 190-HARE(Y2519A) mutant of the NPLY motif retained 85–90% of 
wild type endocytosis, whereas this mutation in the triple motif de-
letant decreased endocytosis to ~7% of wild type. Tyr in NPLY2519 is 
thus important for endocytosis. All HARE mutants showed similar 
HA binding and degradation of the internalized HA, indicating that 
altering endocytic motifs did not affect ectodomain binding of HA or 
targeting of internalized HA to lysosomes. We conclude that, although 
NPLY may be the most important motif, it functions together with two 
other endocytic motifs; thus three signal sequences (YSYFRI, FQHF, 
and NPLY) provide redundancy to mediate coated pit targeting and 
endocytosis of HARE.
Abbreviations: GAG, glycosaminoglycan; aa, amino acids; Ab, an-
tibody (IgG); BSA, bovine serum albumin; CD, cytoplasmic domain; 
CS, chondroitin sulfate; ECM, extracellular matrix; EV, empty vec-
tor; HA, hyaluronic acid, hyaluronate, hyaluronan; HARE, HA recep-
tor for endocytosis; HBSS, Hanks’ balanced salts solution; hHARE, hu-
man HARE; M1, HARE CD motif 1 (YSYFRI); M2, HARE CD motif 2 
(FQHF); M3, HARE CD motif 3 (NPLY); M4, HARE CD motif 4 (DPF); 
PBS, phosphate-buffered saline; TBS, Tris-buffered saline; 190-HARE, 
190-kDa HA receptor for endocytosis; 315-HARE, 315-kDa HA recep-
tor for endocytosis; DMEM, Dulbecco’s modified Eagle’s medium; 
TEMED, tetramethylethylenediamine; ERK, extracellular signal-regu-
lated kinase; WT, wild type; LDL, low density lipoprotein
 
The GAGs, which are primarily located at the cell surface 
or in the ECM, constitute a polysaccharide family that includes 
the chondroitin sulfates, heparin, heparan sulfate, keratan sul-
fate, dermatan sulfate, and HA. HA is found in essentially all 
vertebrate tissues, is often a major ECM constituent (,1), and 
is abundant in young skin, synovial fluid, vitreous humor of 
the eye, and other tissues (e.g. umbilical cord). The size range 
of HA (up to ~107 Da) is much greater than other GAGs (<105 
Da). Unlike other cell surface receptors for HA, such as CD44 
and CD168, HARE mediates the rapid endocytosis of HA via 
the clathrin-coated pit pathway (2–4) in an endocytic process 
similar to that for transferrin, asialoglycoprotein, mannose 
6-phosphate, and low density lipoprotein receptors (5, 6). Al-
though named for its first known function (3), HARE is a gen-
eral receptor for GAG clearance, mediating the endocytosis of 
CS-A, CS-C, CS-D, CS-E, heparin, and dermatan sulfate (CS-B) 
(7, 8). Heparan sulfate and keratan sulfate are the only GAGs 
that are not ligands for HARE (63). 
Despite its simple linear structure (i.e. a polymer of 
2-deoxy,2-acetamido-d-glucopyranosyl-β(1,4)-d-glucurono-
pyranosyl-β(1,3) disaccharide units), HA is a very dynamic 
molecule, whose synthesis and degradation appear tightly 
regulated. Mammals degrade and resynthesize about one-
third (~5 g) of their total body HA daily. The metabolic half-
life of HA varies from ~1.5 day in skin (9) to 2–3 weeks in car-
tilage (10). Similarly, circulating HA has a half-life of 2–5 min, 
because of its rapid clearance by liver sinusoidal endothe-
lial cells (10, 11). In mammals, large native HA (~107 Da) in 
ECMs throughout the body is partially degraded to fragments 
of ~106 Da that are released into lymphatic fluid and flow to 
lymph nodes where sinusoidal endothelial cells remove and 
degrade ~85% of the HA. The remaining HA (~15%) passes 
through the lymph nodes, enters the blood, and is removed 
by the liver via receptor-mediated endocytosis. Although 
HA turnover is high, HARE in sinusoidal endothelial cells of 
lymph nodes and liver keeps the steady-state HA concentra-
tion in blood low (10–100 ng/ml). A high level of HA in the 
blood circulation could elevate blood viscosity and impair the 
microcirculation in capillaries. 
Full-length hHARE is a 2551-aa type I single transmem-
brane glycoprotein (~315 kDa in SDS-PAGE) encoded by the 
180.2-kb STAB-2 gene on chromosome 12q23.3; the gene has 
69 exons. HARE proteins were first purified from rat liver (12) 
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and human spleen (13). Two isoforms of HARE are present 
in tissues (e.g. 190- and 315-kDa hHARE). The smaller HARE 
isoform is derived by proteolysis from the full-length protein 
(7, 14). Both HARE isoforms are functional membrane recep-
tors that bind and internalize ligands via the clathrin-coated 
pit pathway, targeting them to lysosomes for degradation 
(2, 4, 7, 8). The 190-HARE (Figure 1A) has a large extracellu-
lar domain (1323 aa), a transmembrane domain (21 aa), and 
a small (72 aa) COOH-terminal CD (13, 15). The CD (Tyr2480–
Leu2551) contains 17 aa that could be phosphorylated: four 
Tyr, seven Ser, one His, and five Thr. Only Ser2497, Ser2537, 
Thr2523, Tyr2519, and Tyr2531 are predicted to be phosphor-
ylated (by NetPhos 2.0). The CD does not contain PEST se-
quences for rapid protein degradation and turnover or for O-
glycosylation with GlcNAc. 
Endocytic receptors contain either single or multiple tar-
geting sequences that direct the receptor-ligand complexes 
into a coated pit pathway (5, 16, 17). There may be multiple 
coated pit pathways for internalizing and then creating dif-
ferent microenvironments for different receptor-ligand com-
plexes so they are routed or assemble signaling complexes in 
different ways appropriate for the particular receptor (6, 18, 
19). In contrast to single motif receptors, the HARE CD con-
tains five putative endocytic motifs (Figure 1 and Table 2): 
YSYF2483, YFRI2485, FQHF2495, NPLY2519, and DPF2534. The first 
three (YSYF, YFRI, and FQHF) are ΦXXB motifs; where Φ is 
either Tyr or Phe, X can be any aa, and B is a hydrophobic aa 
with a bulky side chain. The first two sequences are overlap-
ping, located at the junction between the membrane and CD, 
and for practical reasons we consider them to be a single mo-
tif, YSYFRI2485. The functions of ΦXXB, NPXY, and DP(F/P) 
motifs in receptor internalization, trafficking, and delivery of 
ligand to lysosomes have been studied extensively in different 
receptors (Table 2). Many receptors contain NPXY motifs that 
facilitate rapid internalization of receptor-ligand complexes 
from the cell surface. 
We recently found that HARE is a signaling receptor able 
to sense external HA and initiate intracellular activation of the 
mitogen-activated protein kinase ERK (64). Thus, we are inter-
ested in how HARE is targeted for internalization and intracel-
lular routing. In this study, our goal was to determine which 
of the four candidate targeting motifs in the CD of HARE 
are important or critical for efficient endocytosis of HA by 
the coated pit pathway. The results indicate that three motifs 
are important, and thus provide substantial redundancy, for 
coated pit targeting and internalization. 
Experimental Procedures
Materials and Buffers—Pfu Ultra DNA polymerase for site-
directed mutagenesis was from Stratagene (La Jolla, CA), and 
super-competent DH10B-derived Escherichia coli, TOP10 E. coli, 
restriction enzymes, cell culture reagents, and hygromycin B 
were from Invitrogen. Plasmid DNA was purified using Ep-
pendorf Miniprep (Westbury, NY) or Maxiprep plasmid iso-
lation kits (Promega, Madison, WI). Protease inhibitor mixture 
(catalogue P8340) and alkaline phosphatase conjugated to anti-
goat or anti-mouse polyclonal Abs were from Sigma. Anti-V5 
Ab was from Bethyl Labs (Montgomery, TX). Horseradish per-
oxidase conjugated to anti-goat or anti-mouse polyclonal Abs 
were from Santa Cruz Biotechnology (Santa Cruz, CA). SDS, 
Tris, acrylamide, bis-acrylamide, TEMED, ammonium per-
sulfate, high range protein molecular weight markers, p-nitro 
blue tetrazolium, and 5-bromo-4-chloro-3-indolyl phosphate 
p-toluidine were from Bio-Rad. Solutions for dye binding pro-
tein assays (20) and reagents for enhanced chemiluminescence 
were from Pierce. Autoradiography film was from Molecular 
Technologies (St. Louis, MO). Na 125I was obtained from GE 
Healthcare, and 125I-HA was prepared as described previously 
(21, 22). Nitrocellulose and polyvinylidene difluoride mem-
brane were from Millipore (Billerica, MA). Unless specified 
otherwise, other chemicals and analytical reagent of the high-
est purity available were from Sigma or Fisher. Growth Me-
dium is DMEM containing 8% (v/v) fetal bovine serum and 
100 μg/ml hygromycin B. TBS contains 20 mm Tris-HCl, pH 
7.0, and 150 mm NaCl. TBST is TBS with 0.1% (v/v) Tween 
20. TBST/BSA is TBST with 1.0% (w/v) BSA. PBS contains 
137 mm NaCl 8 mm Na2HPO4 1.5 mm KH2PO4, 2.7 mm KCl, 
pH 7.2. HBSS contains 5 mm KCl, 0.4 mm KH2PO4, 0.8 mm 
MgSO4, 137 mm NaCl, 0.3 mm Na2HPO4, 5.5 mm glucose, 
1.26 mm CaCl2, 0.5 mm MgCl2, and 28 μm phenol red; at the 
time of use, 3.5 g/100 ml of NaHCO3 was added, and the pH 
was adjusted to 7.2 with HCl. Endocytosis Medium contains 
DMEM supplemented with 0.05% (w/v) BSA. Lysis Buffer is 
PBS with 0.5% (v/v) Nonidet P-40, 200 μm PMSF, and 1 μg/
ml of protease mixture inhibitor (contains 4-(2-aminoethyl) 
benzenesulfonyl fluoride, pepstatin A, E-64, bestatin, leu-
peptin, and aprotinin). 
PCR-assisted Site-directed Mutagenesis—Purified plasmid 
DNA (pSecTag/FRT/V5 His-TOPO; Invitrogen) containing 
190-HARE cDNA (4248 bp) ligated into the BamHI site was 
used as a template to generate the different cDNA mutants 
(8). Primers (Table 1) were designed for deletion or site-di-
rected mutagenesis of coding regions for individual and mul-
tiple potential endocytic motifs in WT 190-HARE plasmid 
DNA. Mutagenesis PCRs were performed for 18 cycles (94 °C 
for 20 s, 55–65 °C for 20 s, and 72 °C for 9 min). Parental and 
newly generated plasmid DNAs were precipitated with 0.1 
volume 3 m potassium acetate, pH 5.5, and 2 volumes of 100% 
ethanol. The DNA pellet was dissolved in 17 μl of water and 
digested with 5 units of DpnI overnight to eliminate paren-
tal DNA. After heat inactivation of DpnI, the DNA solution 
was used to transform TOP10 E. coli using standard manufac-
turer protocols. Bacterial colonies were picked, and potential 
190-HARE mutant cDNAs were verified by PCR using gene-
specific forward (5′-GTTCCATCTACGATCGCCACTGGGC-
CAG-3′) and vector-specific reverse (5′-CGTAGAATCGAGA-
CCGAGGAG-3′) primers. The complete sequences of the 
promoter and complete coding regions of cDNAs in the final 
clones were determined to be correct before use in subsequent 
experiments. All 190-HARE mutants also contain COOH-ter-
minal V5 and His6 epitopes. 
Selection and Characterization of Stable Transfectants—Flp-
In 293 cells (60–70% confluent in a 100-mm plate with 10 ml 
of fresh DMEM) were transfected with 750 μl of serum-free 
DMEM containing 9 μg of pOG44 (which encodes the Flp-In 
recombinase), 1 μg of mutant pSecTag-190-HARE, and 20 μl 
of Lipofectamine 2000 (Invitrogen). Cells were incubated over-
night in Growth Medium without hygromycin B, and then 
washed and fed with fresh Growth Medium for the first 3–4 
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days and then periodically when required. After 2 weeks, in-
dividual isolated colonies were collected and grown in 24-well 
plates until confluent. Clones were tested for HARE protein 
expression by SDS-PAGE, using 5% gels, followed by Western 
blot analysis (23) with anti-V5 Ab. Each clone was also tested 
for correct insertion of the mutant pSecTag-190-kDa hHARE 
cDNA uniquely into the Flp-In recombination site by the Flp-
In recombinase encoded by pOG44, as described previously 
(7, 8). At least 4–6 clones of each mutant were selected and 
characterized for further experiments. 
125I-HA Binding Assays for Cell Surface and Intracellular Re-
ceptors—WT 190-HARE, EV, and mutant 190-HARE cell lines 
were grown to ~90% confluence in Growth Medium in 12-
well tissue culture plates. Cultured cells were washed with 1 
ml of sterile PBS and 1 ml of serum-free DMEM and were in-
cubated at 37 °C in 1 ml of serum-free medium for 1 h. After 
incubation, medium was removed, and the cells were washed 
with 2 ml of HBSS and incubated for 2 h at 4 °C in Endocy-
tosis Medium with 1.5 μg/ml 125I-HA with or without a 100-
fold excess of unlabeled HA to assess nonspecific binding. To 
determine total HA binding (by cell surface and intracellular 
receptors), cells were permeabilized with 0.055% (w/v) digi-
tonin (24, 25) and incubated with 125I-HA ± unlabeled HA as 
above for 2 h at 4 °C. Media were aspirated, and the cells were 
washed rapidly three times with HBSS (2 ml per wash) to re-
move unbound 125I-HA. Cells were then lysed in 1 ml of 0.3 n 
NaOH, and radioactivity was measured using a Packard Co-
bra II gamma counter, and protein was determined by the 
method of Bradford (20) using BSA as standard. Data are ex-
pressed as fmol/106 cells ± S.E. and normalized for HARE ex-
pression relative to WT HARE. Cell number was calculated 
based on 398 μg of total protein/106 cells (8). Specific binding 
was calculated as binding without unlabeled HA (total) minus 
binding in the presence of unlabeled HA (nonspecific). Experi-
ments were performed with each clone in triplicate. 
125I-HA Internalization and Degradation Assays—To assess 
internalization of 125I-HA, WT 190-HARE, EV, and mutant 
HARE cell lines were grown to ~90% confluence, washed, and 
incubated in serum-free medium as above. Cells were washed 
with 2 ml of HBSS and incubated at 37 °C in Endocytosis Me-
dium containing 1.5 μg/ml 125I-HA with or without a 100-fold 
excess of unlabeled HA to assess nonspecific binding, for 2 or 
4 h, unless noted otherwise. Medium was aspirated, and cells 
were washed three times with HBSS (2 ml each), solubilized 
with 1 ml of 0.3 n NaOH, and radioactivity and protein con-
tent were determined as above. Specific HA endocytosis or 
degradation was calculated as the mean value (as fmol/106 
cells/HARE expression relative to WT HARE) without unla-
beled HA (total) minus the value in the presence of unlabeled 
HA (non-specific). Each experiment was repeated 2–3 times 
with multiple clones. 
Degradation of internalized 125I-HA was measured using a 
cetylpyridinium chloride precipitation assay as described pre-
viously (26, 27). Cells were lysed in 0.3 n NaOH, and 100-μl 
samples were mixed at 22 °C with 47 μl of 0.6 n HCl, 28 μl 
of distilled water, and 125 μl of 2.0 mg/ml HA in 1.5-ml mi-
crocentrifuge tubes. Cetylpyridinium chloride (300 μl of 6%; 
w/v) in distilled water was added, and the tubes were mixed 
by vortexing, and after 10 min, the samples were centrifuged 
(22 °C, 5 min, 9000 rpm) in a microcentrifuge, using a swing-
ing bucket rotor. A supernatant sample (300 μl) was taken to 
determine radioactivity, and the rest was removed by aspira-
tion. The tube tip containing the precipitated pellet was cut 
off and put in a gamma counter tube, and radioactivity was 
determined. Degradation values were calculated as the time-
dependent increase of nonprecipitable radioactivity and are 
expressed as the percent (with WT as 100%) of specifically in-
ternalized 125I-HA that was degraded. 
Western and Ligand Blot Assays—To analyze and normalize 
for HARE expression in mutant cell lines, cells at ~90% con-
fluence in 6-well plates were washed twice with cold PBS and 
solubilized in Lysis Buffer. Lysates were mixed by vortexing, 
incubated on ice for 2 h, and centrifuged at 11,250 × g for 5 
min to remove debris. Samples (25 μg of protein) were sepa-
rated in 5% gels by nonreducing SDS-PAGE, followed by elec-
tro-transfer to nitrocellulose membranes for 1 h, 4 °C at 110 V 
in 25 mm Tris-HCl, 192 mm glycine, pH 7.4, and 20% (v/v) 
methanol. For Western blot analysis of WT and mutant 190-
HARE protein, membranes were treated with TBST/BSA for 1 
h, washed, and incubated with anti-V5Ab for 1 h at 22°C. Blots 
were washed three times (5 min each) with TBST/BSA, incu-
bated with goat anti-rabbit Ab conjugated to alkaline phos-
phatase (or horse-radish peroxidase), washed three times 
with TBST/BSA, and incubated with p-nitro blue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine-conju-
gated Ab for color development using alkaline phosphatase. 
Reactions were stopped by washing the membrane with dis-
tilled water. For horseradish peroxidase detection, membranes 
Table 1. Primer sequences used to create mutations in the 190-HARE CD. Deletion or substitution mutations were made as described under 
“Experimental Procedures” using the indicated forward (F) and reverse (R) primers. Deletion of multiple motifs was accomplished by using a 
single, double, or triple motif deletion mutant HARE cDNA and a set of primers to delete codons specifying another motif. 
190-HARE mutant  Forward and reverse mutagenic primer sequences
(ΔYSYFRI) = ΔM1  F, 5′-GTTGCCTTGGCTGCTAACCGGAGAAC-3′
 R, 5′-GATTGTTCTCCGGTTAGCAGCCAAGG-3′
(ΔFQHF) = ΔM2  F, 5′-CGGAGAACAATCGGCGAGTCGGAAGAGGAC-3′
 R, 5′-GTCCTCTTCCGACTCGCCGATTGTTCTCCG-3′
(ΔNPLY) = ΔM3  F, 5′-CAGCAGCCTGAGAATATCTCGGAGAGCACAACCTCAGCTCCC-3′
 R, 5′-GGGAGCTGAGGTTGTGCTCTCCGAGATATTCTCAGGCTGCTG-3′
(ΔDPF) = ΔM4  F, 5′-CCAGAACCTTCCTACACGGACTCTGAAGAAC-3′
 R, 5′-GTTCTTCAGAGTCCGTGTAGGAAGGTTGCTGG-3′
Y2519A  F, 5′-GAGAATATCTCGAACTTGGCTGAGAGCACAACC-3′
 R, 5′-GGTTGTGCTCTCAGCCAAGTTCGAGATATTCTC-3′
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were incubated with enhanced chemiluminescence substrate 
and exposed to autoradiography film. For comparison of 190-
HARE protein expression levels by mutant cell lines (with 
replicates of 4–6 clones per group), HARE band intensities in 
Western blots (with equal total cell protein loads) were quan-
tified by densitometry using a FluoroChem8000 Imaging Sys-
tem (Alpha Innotech Corp, San Leandro, CA). Band intensities 
were normalized to parallel wild type 190-HARE samples and 
expressed as a percent of WT HARE expression. 
For ligand blot assays, the post-transfer membranes were 
incubated with TBST for 2 h or overnight at 4 °C. To reduce 
nonspecifically bound material, and thus background, solu-
tions of 1.5 μg/ml 125I-HA in 10 mm HEPES, pH 7.4, 150 mm 
NaCl, 5 mm EDTA, with or without a 100-fold excess of un-
labeled HA, were first exposed to unused nitrocellulose at 22 
°C for 2 h. The protein-containing membranes were then incu-
bated with the treated 125I-HA solutions for 2 h at 4°C, washed 
five times (5 min each) with TBST, air-dried at 22 °C for 30 
min, and bound 125I-HA was detected by autoradiography us-
ing Kodak BioMax MS film exposed for 1–15 days at -80 °C. 
The same membrane was washed with TBST/BSA and then 
probed with anti-V5 Ab to assess HARE expression. 
Data Analysis—The assessment of statistical significance for 
differences between sample sets, based on three independent 
experiments, was by the unpaired Student’s t test. 
Results
Whereas many membrane receptors have a single CD se-
quence that mediates efficient uptake into the coated pit path-
way, HARE has multiple candidate motifs for this purpose 
(Figure 1A and Table 2). Involvement of multiple motifs might 
indicate that redundancy is critical, perhaps for multiple func-
tions of HARE, or that different HARE-ligand complexes 
may follow alternative intracellular pathways. To determine 
whether any of the four putative endocytic motifs in the HARE 
CD are active for targeting to coated pits, we created a panel 
of stable Flp-In 293 cell lines expressing 190-HARE mutants 
Figure 1. The 190- and 315-HARE CD and mutants used in this study. A, four putative endo-
cytic motifs (indicated in boldface and overlined) are present in the 72-aa CD of recombinant 190-
HARE (1416 aa long) or 315-HARE (2551 aa long). The four sequence motifs (YSYFRI2485, FQHF2495, 
NPLY2519, and DPF2534) are referred to as M1, M2, M3, and M4, respectively. Numbering is relative 
to the full-length 315-HARE protein (13, 15). V5 and His6 epitopes are at the COOH termini of all 
190-HARE mutants. B, scheme illustrates the various motif deletion or site-specific 190-HARE CD 
mutants used. Constructs and stably transfected Flp-In-293 cell lines were prepared as described 
under “Experimental Procedures.” TM, transmembrane. 
Table 2. Potential endocytic signals in HARE. The candidate endocytic signals (M1–M4) in the HARE CD, their recognition partners, and potential 
functions are summarized. The first motif contains two overlapping YXXΦ motifs as indicated by the sequences that are underlined or in boldface font. 
HARE     Targeting   
sequence    motif      Proposed recognition protein       Function     References
YSYFRI2485  YXXΦ (ΦXXB)  μ subunits of AP complex  Internalization, basolateral, or lysosomal targeting  43, 44, 59–62
FQHF2495  ΦXXB  μ subunits of AP complex  Internalization, basolateral, or lysosomal targeting  43, 44, 59–62
NPLY2519  NPXY  μ2 subunit of AP-2, Dab2 Tyr(P)  Internalization, intracellular, routing/signaling  42, 47, 49, 50
      binding domain, clathrin
DPF2534  DPF/DPW  Ear domain of the α subunit  Internalization process  34, 35, 37 
     of AP-2 complex
with different endocytic motif dele-
tions or substitution mutations (Fig-
ure 1B). Cells expressing mutant 190-
HARE protein that were negative for 
β-galactosidase and sensitive to Zeo-
cin represented the correct insertion 
of vector into the single recombinase-
specific site in Flp-In 293 cells. We ex-
amined multiple clones of the fol-
lowing 190-HARE mutant cell lines 
containing single motif deletions 
(ΔYSYFRI (ΔM1), ΔFQHF (ΔM2), 
ΔNPLY (ΔM3) or ΔDPF (ΔM4)); a 
double motif deletion (ΔM1M2), tri-
ple motif deletions (ΔM1M2M4) 
without and with a Y2519A substitu-
tion in M3, and a quadruple motif de-
letion (ΔM1M2M3M4). 
We selected 4–6 individual cell 
line clones for each mutant and mea-
sured HARE expression in repli-
cates of each group of clones by 
SDS-PAGE, Western analysis, and 
densitometry using equal amounts of 
total cell lysate protein as measured 
by the Bradford assay. Although a 
single blot is shown (Figure 2A), the 
overall results (not shown) demon-
strated that HARE expression within 
each group of mutants was ~85–100% 
of the WT 190-HARE protein level. 
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Each HARE CD mutant also contains V5 and His6 epitopes at 
the COOH terminus. No differences were found in the mor-
phology or cell growth characteristics among the mutant cell 
lines, compared with 190-HARE cells (data not shown). Li-
gand blot assays were performed to quantify specific 125I-HA 
binding to the various HARE mutants after SDS-PAGE and 
electrotransfer to nitrocellulose (28). Densitometry of auto-
radiographs followed by Western blot analysis allowed HA 
binding to be normalized for HARE protein content, relative 
to WT (Figure 2B). All of the HARE CD mutants lacking indi-
vidual or multiple endocytic motifs bound 125I-HA in ligand 
blot assays essentially at WT levels. The HARE CD mutants 
also bound comparable amounts of three anti-hHARE mAbs, 
compared with WT HARE, indicating there were no changes 
in the folding of the mutant HARE ectodomains (not shown). 
Typically, endocytic recycling receptors constitutively recy-
cle and are found both on the cell surface and in numerous in-
tracellular compartments, representing different stages of the 
receptor routing and recycling pathway. The majority of such 
endocytic receptors, including HARE, are intracellular, and 
this cellular distribution of receptor molecules reflects the ki-
netic steady-state of the receptor pathway, which is both ki-
netic and spatial. If mutation of an important motif sequence 
affected the intracellular routing/recycling kinetics of HARE, 
then the normal steady-state receptor distribution could also 
be altered. To test this, cell lines expressing a variety of 190-
HARE CD mutants were assessed for cell surface and total (i.e. 
cell surface and intracellular receptors in digitonin-permeabi-
lized cells) binding of 125I-HA (Figures 3A and 4A). All 190-
HARE single mutant cells bound 125I-HA at the cell surface and 
to intracellular sites at WT levels (Figure 3A). Among the mul-
tiple motif deletion mutants, only the ΔM1/M2/M4 + Y2519A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HARE mutant displayed significantly less cell surface (p =  
0.004) HARE and total (p = 0.02) HARE than WT (Figure 4A). 
However, the ΔM1/M2/M4 + Y2519A HARE mutant showed 
a surface/internal HARE distribution that was similar to WT. 
Thus, all the 190-HARE CD motif-deletion mutants appear to 
have normal intracellular receptor trafficking and recycling 
kinetics. 
To understand the role of putative signal motifs in endocy-
tosis of HA and targeting HARE to coated pits, cells express-
ing 190-HARE mutants were incubated at 37 °C with 125I-HA 
with or without excess HA to assess nonspecific uptake (Fig-
ures 3B and 4B). Cells expressing 190-HARE(ΔM4) did not 
show any defect in 125I-HA internalization. The specificity of 
125I-HA internalization by the WT and all mutant HARE cell 
lines was >80%. The rates of 125I-HA internalization by HARE 
ΔM1 and ΔM2 mutant cell lines decreased by ~49 and ~39%, 
respectively (Figure 3B). Cell lines expressing a double motif 
Figure 2. Expression and 125I-HA ligand binding of 190-HARE CD 
mutants. Cells were grown to confluence, washed twice with cold 
PBS, and centrifuged cell lysates (25 μg of protein) were subjected 
to SDS-PAGE and electrotransfer. A, HARE protein was detected by 
Western blot analysis using anti-V5 Ab. The 190-HARE proteins are 
as follows: lane 1, WT; lane 2, ΔM1; lane 3, ΔM2; lane 4, ΔM3; lane 5, 
ΔM4; lane 6, ΔM1M2; lane 7, ΔM1M2M4; lane 8, Y2519A; and lane 9, 
EV. B, ligand blot assays were performed with 125I-HA in multiple ex-
periments using different clones of the indicated mutants, and HARE 
expression was determined by Western blotting using the same strips 
after autoradiography. 125I-HA ligand blot signals were normalized to 
HARE expression using densitometry and to WT (as 100%). 
Figure 3. 125I-HA binding and endocytosis by cells expressing sin-
gle motif 190-HARE CD mutants. Cells expressing EV, WT, or mu-
tant 190-HARE were incubated in serum-free medium and washed, 
and specific 125I-HA binding at 4 °C or endocytosis at 37 °C was quan-
tified as described under “Experimental Procedures.” A, cell surface 
and total cellular 125I-HA binding are indicated for cells expressing 
190-HARE: WT (white bars), ΔM1 (horizontal rectangles), ΔM2 (diagonal 
rectangles), ΔM3 (diagonal lines), or ΔM4 (arrowheads) 190-HARE or EV 
(black). Values from 2 to 3 independent experiments are the means ± 
S.E. (n = 6–9) specific 125I-HA binding normalized for HARE expres-
sion relative to WT 190-HARE. B, specific 125I-HA internalization 
was determined at 37 °C for 2 and 4 h as described under “Experi-
mental Procedures.” Values from 2 to 3 independent experiments are 
the mean ± S.E. (n = 6–9) specific 125I-HA endocytosis, normalized for 
HARE expression relative to WT. The plots show cells expressing WT 
(○), ΔM1 (▼), ΔM2 (Δ), ΔM3 (■), or ΔM4 (□) 190-HARE, or EV (•). 
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(ΔM1M2) or a triple motif (ΔM1M2M4) deletion showed sim-
ilar endocytic rate decreases of ~41% (Figure 4B). The essen-
tially identical rates of HA endocytosis by cells expressing 
HARE ΔM1M2 or ΔM1M2M4 mutants confirm that the DPF 
motif does not play an important role in HARE-mediated en-
docytosis of 125I-HA. Cells expressing HARE lacking the NPLY 
motif (ΔM3) demonstrated ~56% decreased endocytosis rates, 
which indicate that this motif is very important, although not 
absolutely necessary, for HARE internalization. 
After HA is internalized, it is delivered to lysosomes where it 
is then degraded by lysosomal hyaluronidase, β-glucuronidase, 
and β-N-acetylglucosaminidase (10, 26). 125I-HA degradation 
was quantified by a cetylpyridinium chloride precipitation as-
say (26). No significant differences in the amounts of 125I-HA 
degradation were observed for any of the HARE mutants com-
pared with the WT cell lines over 8 h (Figure 5). The results in-
dicate that deletion of different endocytic motifs in the HARE 
CD does not affect delivery to and degradation in lysosomes of 
the 125I-HA internalized by the various mutants. 
To confirm the redundancy of the multiple motifs in the 
HARE CD and further assess their role in HARE internalization, 
we created additional deletion and point mutation mutants of 
M3. Cells expressing a triple motif deletion HARE CD mutant, 
Δ(M1M2M4), were compromised in their ability to endocytose 
HA but still mediated HA uptake at 58% of the WT 190-HARE 
rate (Figure 4B). In contrast, a HARE CD mutant with a sin-
gle Y2519A change in the NPLY signal sequence showed only 
an ~10% reduced rate of HA uptake (Figure 4C); this mutation 
had little effect compared with deletion of the whole M3 motif. 
However, when the Y2519A mutation was combined with the 
triple motif deletion, Δ(M1M2M4), the resulting rate of HARE-
mediated 125I-HA endocytosis was reduced by ~95% (Figure 
4C), to almost the level of background uptake seen in EV cells. 
The result shows that in the absence of the functional redun-
dancy provided by motifs M1 and M2, Tyr2519 is critical for the 
function of motif M3. Table 3 summarizes the 125I-HA endocyto-
sis rates for all the 190-HARE mutants used in this study. 
Discussion
Receptor-mediated endocytosis via the clathrin-coated pit 
pathway is a sequential process, involving many cytosolic 
Figure 4. 125I-HA binding and endocytosis by cells expressing mul-
tiple motif HARE CD mutants. Cells expressing EV, WT 190-HARE, 
or 190-HARE mutants were incubated at 37 °C in serum-free medium 
for 1 h, washed, incubated, and processed to quantify 125I-HA binding 
at 4 °C or endocytosis at 37 °C as described in Figure 3. A, cell surface 
and total cellular 125I-HA binding are indicated for cells expressing 
EV (black) or 190-HARE: WT (white bars), ΔM1M2 (horizontal rectan-
gles), ΔM1M2M4 (diagonal rectangles), ΔM1M2M3M4 (diagonal lines), 
Y2519A (arrowheads), or ΔM1M2M4 + Y2519A (checkerboard). B, endo-
cytosis of 125I-HA by cells expressing 190-HARE: WT (○), ΔM1M2 (▼), 
ΔM1M2M4 (Δ), ΔM1M2M3M4 (■), or EV (●). C, endocytosis of 125I-
HA by cells expressing 190-HARE: WT (○), Y2519A (▼), ΔM1M2M4 + 
Y2519A (Δ), ΔM3 (■), or EV (●). 
Figure 5. Degradation of internalized 125I-HA by cells expressing 
190-HARE mutants. Confluent cells expressing the indicated WT or 
HARE mutants were incubated at 37 °C with 1.5 μg/ml 125I-HA with 
or without 150 μg/ml unlabeled HA for 8 h. Medium samples were 
taken to assess released 125I-HA degradation products and normalized 
as described under “Experimental Procedures.” The values plotted are 
the mean ± S.E. (n = 6) percent degradation of the specifically internal-
ized 125I-HA. 
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proteins at different steps, in which plasma membrane recep-
tors are specifically and efficiently internalized into the cell. 
Based on their interactions with the endocytic cargo (i.e. re-
ceptor-ligand complexes), proteins facilitating endocytosis are 
classified as accessory or adaptor proteins (e.g. AP-2); >30 dif-
ferent adaptor/accessory proteins may be involved in or con-
trol endocytic processes (16, 17, 29). Adaptor proteins bind 
to the endocytic cargo and to coat components, thus linking 
the two (30). Accessory proteins (e.g. dynamin) are involved 
in coated vesicle formation without direct interaction with en-
docytic cargo (31, 32). Although many other proteins are in-
volved in coat-complex formation, clathrin and adaptor pro-
teins, particularly AP-2, are the major proteins in coated 
vesicles (17, 33). Selective recruitment of cargo proteins into 
coated pits is mediated by μ2 subunits of AP-2 binding to spe-
cific short sequences (3–7 aa) in a receptor CD. These signal se-
quences are highly, although not exactly, conserved in differ-
ent organisms, and 2–3 aa of a signal motif are usually crucial 
for function. Two major classes of endocytic signal motifs are 
predominantly involved in targeting to the coated pit path-
way: those that have Tyr as a critical endocytic aa (e.g. NPXY 
and YXXΦ) and those with di-Leu (e.g. DEXXX(L/L)I). Acces-
sory proteins implicated in endocytosis process such as Epsin, 
(34), Eps15 (35, 36), and Dynamin (37) have DPW or DPF sig-
nal sequences that bind the α-adaptin appendage domain. 
The 72-aa HARE CD contains four potential signal se-
quence motifs (YSYFRI2485, FQHF2495, NPLY2519, and DPF2534) 
that could be used to target ligand-HARE complexes to the 
clathrin-coated pit pathway for rapid endocytosis. As ex-
pected, deleting any of these CD motifs had little or no effect 
on 125I-HA binding by their respective HARE ectodomains 
or on HARE protein expression levels. All HARE mutants 
were also recognized by three hHARE-specific mAbs orig-
inally raised against rat HARE suggesting that the ecto-do-
main is not affected by CD mutations (3, 13). However, cells 
expressing single or multiple deletions of motifs M1, M2, or 
M3 showed very similar (~38–52%) decreases in 125I-HA in-
ternalization rates. In contrast, deletion of M4 (DPF2534) did 
not affect 125I-HA endocytosis. Moreover, all of the 190-HARE 
CD mutants tested showed no defects in the ability to deliver 
the internalized HA to lysosomes, i.e. deletion of different po-
tential endocytic motifs in HARE did not affect the traffick-
ing pathways that deliver internalized HA from plasma mem-
brane to lysosomes. In all but two of the HARE CD mutants, 
intracellular receptor routing and recycling appeared to be un-
affected. The results do not exclude the possibility that some 
of the signal sequences are involved in both coated pit target-
ing and intracellular routing. 
Several classes of endocytic motifs present in the CD of 
membrane proteins have been identified that utilize clathrin-
coated pits for endocytosis. Among these signals, Tyr-contain-
ing signal motifs such as YXXΦ and NPXY are the best char-
acterized. Cells expressing 190-HARE(ΔM1) showed slower 
125I-HA internalization rates (~49%) compared with WT, indi-
cating that YSYFRI2485, with two overlapping YXXΦ motifs, is 
important but not essential for endocytosis. Tyr in the CD of 
endocytic recycling receptors (e.g. cation-independent man-
nose 6-phosphate, asialoglycoprotein, and transferrin recep-
tors (5, 38)) is essential for binding the μ2 subunit of AP-2 and 
for accumulation into clathrin-coated pits and rapid internal-
ization (39–41). The dominant signal for β-amyloid precursor 
protein endocytosis is also a YXXΦ motif, YENP (42). YXXΦ 
motifs are not limited to only endocytic targeting, they can 
also help target transmembrane proteins to lysosomes and lys-
osome-related organelles (43), and sort membrane receptors to 
the basolateral plasma membrane of polarized epithelial cells 
(44) or to the trans-Golgi network (5, 30, 45). 
Tyr is also critical in NPXY endocytic signal motifs, which 
are highly conserved from Caenorhabditis elegans and Drosoph-
ila melanogaster to mammals, indicating that they participate in 
evolutionarily conserved sorting mechanisms. The NPXY sig-
nal motifs in other type I integral membrane receptors such 
as the LDL receptor, LDL receptor-related protein, integrin β, 
and β-amyloid precursor protein mediate rapid endocytosis 
via coated pits (42, 46–50). Generally, NPXY signals are found 
in medium length CDs (e.g. ~40–200 aa), not closer than 10 aa 
from the membrane domain and not present at the very end of 
the CD. In hHARE, the NPLY2519 sequence is in the center of 
the 72-aa-long CD. 
This is the first effort to address the functional roles of 
YXXΦ, DPX, and NPXY motifs in the endocytosis of hHARE-
ligand complexes. The hHARE CD actually has three ΦXXB 
motifs: the overlapping YSYF and YFRI sequences in M1 and 
the M3 motif FXXF2495. Interestingly, the rat HARE CD has cor-
responding and nearly identical YSYFRL (M1) and FQRF (M2) 
sequences but does not contain DP(F/W) or NPXY motifs (13, 
14). Our results indicate that although NPLY2519 (M3) is slightly 
more important for endocytosis by hHARE, the YSYFRI2485 
(M1) and FQHF2495 (M2) sequences also contribute substan-
tially to the overall internalization of HA. Thus, no single mo-
tif was critical for rapid uptake of HARE, and the three motifs 
provide, for as yet unknown reasons, unexpected redundancy 
for internalization. Redundancy may be needed for functions 
of HARE other than just GAG clearance. One newly discovered 
function is the recent finding that HARE is a signaling recep-
tor that mediates intracellular activation of ERK1 and -2, in re-
sponse to the concentration of external HA (64). Perhaps one of 
the three active endocytic signal sequences is also specifically 
involved in activation of the ERK signaling pathway. 
Table 3. Rates of 125I-HA endocytosis by 190-HARE CD variants Cells 
expressing the indicated 190-HARE mutants, WT, or EV were assessed 
for specific 125I-HA endocytosis and normalized to total protein and 
then cell number, and HARE expression relative to WT as described 
under “Experimental Procedures.” Values are the mean ± S.E. (n = 6–9). 
190-HARE mutant               Specific 125I-HARE       Relative HA uptake 
 fmol/106 cells/WT HARE/h     %
WT  295 ± 5  100
EV  0.5 ± 0.3  0.2
ΔM1  151 ± 5a,b  51
ΔM2  180 ± 2b  61
ΔM3  129 ± 4a  44
ΔM4  351 ± 6  119
ΔM1M2  182 ± 2  61
ΔM1M2M4  172 ± 4  58
ΔM1M2M3M4  21 ± 3  7
Y2519A  279 ± 19  94
ΔM1M2M3 + Y2519A  14 ± 2  5
a. Data indicate that the rates for the ΔM1 and ΔM3 mutants, compared 
with each other, were significantly different; p < 0.002.
b. Data indicate that the rates for ΔM1 and ΔM2 mutants were 
significantly different; p < 0.001.
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Some receptors have a single signal motif for internaliza-
tion. For example, substitution of Tyr807 with Cys or Ala re-
duces endocytosis by ~85% in the LDL receptor, whereas sub-
stitution with Phe does not abolish rapid internalization. An 
NPXY motif in the insulin-like growth factor I receptor is the 
primary motif for internalization and is also involved in the 
signaling pathway (51). Other receptors possess multiple mo-
tifs for internalization, so that mutation or deletion of a sin-
gle motif often does not completely abolish receptor inter-
nalization. For example, two NPXY motifs in integrin β1 are 
required for recruitment to focal adhesions (52), and the CD 
of megalin has two NPXY motifs that are both important for 
coated pit targeting (53). The interleukin-13 receptor α2 con-
tains a diLeu- and a Tyr-based endocytic motif, and substitu-
tion or deletion of either motif decreases endocytosis of 125I-
interleukin-13 by ~50%, indicating that both endocytic motifs 
work together for internalization (54). In some proteins, en-
docytic motifs are not involved in endocytosis and therefore 
not signal sequences. The angiotensin II receptor contains four 
candidate Tyr-based motifs and one diLeu-based motif, but 
only Tyr319 and LL316 are important for efficient receptor inter-
nalization (55). The CD of the receptor for LDL-related protein 
1 contains one YXXΦ, two NPXY, and two diLeu motifs. How-
ever, only the YXXΦ and one diLeu are dominant endocytic 
signals for targeting receptor to coated pits (56). 
It may not be surprising that multiple endocytic motifs 
are involved in HARE-mediated internalization of 125I-HA. 
Although we have characterized HARE most extensively 
as an HA receptor, it also specifically binds and internal-
izes many other ligands. In addition to HA and multiple CS 
types, HARE/Stabilin 2 specifically recognizes advanced gly-
cation end products (e.g. AGE-BSA) and acetylated-LDL (57), 
which we have confirmed. We also recently discovered that 
the 190-HARE and 315-HARE proteins are endocytic receptors 
for heparin (63). Thus, HARE binds and internalizes sulfated 
(CS, DS, and heparin) and nonsulfated (HA and chondroi-
tin) GAGs and advanced glycation end products. Nonethe-
less, HARE is specific and does not simply bind any anionic 
polymer, because heparan sulfate, keratan sulfate, polygalact-
uronic acid, and nucleic acids are not ligands (2, 7, 8, 58). 
In summary, the results show that NPLY2519 is a slightly 
more active endocytic signal sequence in the CD of 190-HARE 
than YSYFRI2485 or FQHF2495. In contrast, deletion of the 
DPF2534 sequence motif did not affect endocytosis. Thus, the 
maximum rate of HARE endocytosis requires that the three 
endocytic motifs (YSYFRI, FQHF, and NPLY) work together 
for efficient coated pit targeting and endocytosis of HARE. 
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